Shelley E. Crary

1.9k total citations
36 papers, 640 citations indexed

About

Shelley E. Crary is a scholar working on Surgery, Hematology and Genetics. According to data from OpenAlex, Shelley E. Crary has authored 36 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 10 papers in Hematology and 9 papers in Genetics. Recurrent topics in Shelley E. Crary's work include Vascular Malformations and Hemangiomas (11 papers), Hemoglobinopathies and Related Disorders (8 papers) and Vascular Malformations Diagnosis and Treatment (7 papers). Shelley E. Crary is often cited by papers focused on Vascular Malformations and Hemangiomas (11 papers), Hemoglobinopathies and Related Disorders (8 papers) and Vascular Malformations Diagnosis and Treatment (7 papers). Shelley E. Crary collaborates with scholars based in United States, Canada and Italy. Shelley E. Crary's co-authors include George R. Buchanan, Janna M. Journeycake, Gresham T. Richter, Richard W. Nicholas, Timothy L. McCavit, Kelly Stewart, Leah Adix, Claudio Ramaciotti, Henry E. Rice and Jacob C. Langer and has published in prestigious journals such as Blood, The Journal of Pediatrics and Journal of Thrombosis and Haemostasis.

In The Last Decade

Shelley E. Crary

31 papers receiving 619 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shelley E. Crary 275 262 173 84 61 36 640
Heidi Doughty 250 0.9× 195 0.7× 230 1.3× 37 0.4× 27 0.4× 53 1.2k
Janet Birchall 484 1.8× 143 0.5× 123 0.7× 60 0.7× 77 1.3× 21 916
Gili Kenet 762 2.8× 135 0.5× 203 1.2× 134 1.6× 116 1.9× 72 1.1k
Mariana Bonduel 406 1.5× 134 0.5× 90 0.5× 70 0.8× 213 3.5× 35 669
Annette Poon 548 2.0× 122 0.5× 126 0.7× 84 1.0× 122 2.0× 33 812
Suman L. Sood 375 1.4× 115 0.4× 77 0.4× 79 0.9× 215 3.5× 52 871
Oluwatoyosi A. Onwuemene 169 0.6× 130 0.5× 59 0.3× 38 0.5× 69 1.1× 42 454
N. Blumberg 288 1.0× 336 1.3× 57 0.3× 64 0.8× 54 0.9× 24 985
R. Vallance 482 1.8× 254 1.0× 225 1.3× 91 1.1× 88 1.4× 21 1.5k
Jyh‐Pyng Gau 277 1.0× 76 0.3× 95 0.5× 53 0.6× 85 1.4× 74 659

Countries citing papers authored by Shelley E. Crary

Since Specialization
Citations

This map shows the geographic impact of Shelley E. Crary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelley E. Crary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelley E. Crary more than expected).

Fields of papers citing papers by Shelley E. Crary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelley E. Crary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelley E. Crary. The network helps show where Shelley E. Crary may publish in the future.

Co-authorship network of co-authors of Shelley E. Crary

This figure shows the co-authorship network connecting the top 25 collaborators of Shelley E. Crary. A scholar is included among the top collaborators of Shelley E. Crary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelley E. Crary. Shelley E. Crary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sisk, Bryan A., Anna M. Kerr, Margaret T. Lee, et al.. (2025). Knowledge, interest, and willingness of hematologists and oncologists to care for adults with vascular anomalies. Journal of Thrombosis and Haemostasis. 24(1). 171–179.
2.
Crary, Shelley E., et al.. (2024). Anticoagulation and vascular anomalies. Research and Practice in Thrombosis and Haemostasis. 8(3). 102402–102402. 3 indexed citations
3.
O’Connell, Niamh, Paul van der Valk, Sandra Le Quellec, et al.. (2024). Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B. Journal of Thrombosis and Haemostasis. 23(1). 73–84. 1 indexed citations
4.
Kanter, Julie, Parth Patwari, Payal Desai, et al.. (2023). Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study. Blood. 142(Supplement 1). 149–149. 3 indexed citations
5.
Borst, Alexandra J., et al.. (2023). Barriers to Genetic Testing in Vascular Malformations. JAMA Network Open. 6(5). e2314829–e2314829. 3 indexed citations
6.
Goudie, Anthony, Richard T. Fiser, Scott L. Weiss, et al.. (2020). Association Between Elevated RBC Distribution Width and Multiple Organ Dysfunction in Pediatric Critical Illness. Pediatric Critical Care Medicine. 21(9). e740–e746. 3 indexed citations
7.
Blatt, Julie, et al.. (2019). Cancer Risk in Klippel–Trenaunay Syndrome. Lymphatic Research and Biology. 17(6). 630–636. 17 indexed citations
8.
Samanta, Debopam, et al.. (2019). Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome. Pediatric Neurology. 96. 37–39. 4 indexed citations
9.
Richter, Gresham T., et al.. (2018). Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series. Lymphatic Research and Biology. 16(3). 278–281. 22 indexed citations
10.
Estepp, Jeremie H., Chiara Melloni, Courtney D. Thornburg, et al.. (2015). Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. The Journal of Clinical Pharmacology. 56(3). 298–306. 15 indexed citations
11.
Roy, Sani M., George R. Buchanan, & Shelley E. Crary. (2013). Splenectomy in Children With “Mild” Hereditary Spherocytosis. Journal of Pediatric Hematology/Oncology. 35(6). 430–433. 3 indexed citations
12.
Crary, Shelley E., et al.. (2013). Prominent Forehead Hematomas (“Goose-Eggs”) as an Initial Manifestation of Hemophilia. The Journal of Pediatrics. 163(6). 1781–1783. 1 indexed citations
13.
Rice, Henry E., Shelley E. Crary, Jacob C. Langer, & Alex R. Kemper. (2011). Comparative Effectiveness of Different Types of Splenectomy for Children with Congenital Hemolytic Anemias. The Journal of Pediatrics. 160(4). 684–689.e13. 21 indexed citations
14.
Crary, Shelley E., Claudio Ramaciotti, & George R. Buchanan. (2011). Prevalence of pulmonary hypertension in hereditary spherocytosis. American Journal of Hematology. 86(12). E73–6. 17 indexed citations
15.
Crary, Shelley E., et al.. (2010). Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis. Pediatric Blood & Cancer. 55(4). 684–689. 11 indexed citations
16.
Crary, Shelley E., et al.. (2010). Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatric Blood & Cancer. 56(4). 615–619. 57 indexed citations
17.
Crary, Shelley E. & George R. Buchanan. (2009). Vascular complications after splenectomy for hematologic disorders. Blood. 114(14). 2861–2868. 235 indexed citations
18.
Crary, Shelley E., et al.. (2008). Experience with intravenous enoxaparin in critically ill infants and children. Pediatric Critical Care Medicine. 9(6). 647–649. 13 indexed citations
19.
Crary, Shelley E., et al.. (2006). Venous thrombosis and thromboembolism in children with osteomyelitis. The Journal of Pediatrics. 149(4). 537–541. 65 indexed citations
20.
Crary, Shelley E., George R. Buchanan, & Janna M. Journeycake. (2006). Fatal central venous catheter‐related infection in haemophilia. Haemophilia. 12(2). 183–186. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Doughty Breakdown of academic impact, for papers by Janet Birchall Breakdown of academic impact, for papers by Gili Kenet Breakdown of academic impact, for papers by Mariana Bonduel Breakdown of academic impact, for papers by Annette Poon Breakdown of academic impact, for papers by Suman L. Sood Breakdown of academic impact, for papers by Oluwatoyosi A. Onwuemene Breakdown of academic impact, for papers by N. Blumberg Breakdown of academic impact, for papers by R. Vallance Breakdown of academic impact, for papers by Jyh‐Pyng Gau
Rankless by CCL
2026